MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting Litecoin creator Charlie Lee onto its board. That decision comes via a ...

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging with institutional interest and ...

MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or “the Company”) today announced the acquisition of 929,548 Litecoin (LTC) tokens at an average price of $107.58, successfully launching a major institutional ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

GSR, crypto’s capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ ... MEI represents a significant step toward institutionalizing Litecoin as ...

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange ...

Home News Business Wire MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange ...

SAN DIEGO--(BUSINESS WIRE)-- MEI Pharma, Inc. (the “Company” or “MEI”) today announced that it has entered into securities purchase agreements for a private investment in public equity ...